Optimizing Sterile Compounding Best Practices: Leveraging Technologies and Removing Barriers to Improve Safety
Space is limited, and pre-registration is encouraged. Pre-registration is for planning purposes only and seating will be available on a first-come, first-served basis. Food and beverages are not provided at Midday Symposia. This ASHP policy considers the varied internal policies of commercial supporters related to the Physician Payments Sunshine Act. You are welcome to bring your lunch to the session.
The sterile compounding technology market has widened with more products available and more organizations adopting use of technology solutions in the sterile compounding process. Despite these advancements, an ISMP survey on pharmacy compounding practices revealed that opportunities remain to improve the safety of sterile compounding practices as well as increase and enhance the safe use of technology in the process. This symposium will highlight the results from the 2020 ISMP Sterile Compounding surveys which looked at compounding risks, the current use of compounding technologies, and compliance with identified best practices. The symposium speaker team will review the ISMP Guidelines for Sterile Compounding and the Safe Use of Sterile Compounding Technology, with a focus on safe practices related to the use of robotic compounding automation, sterile compounding workflow software, automated compounding devices.
This will be followed by a discussion of one organization’s sterile compounding operations and the role that technology has played to improve safety. The program will conclude with a discussion of common objections that may inhibit organizations from purchasing technology for sterile compounding and address how one organization overcame these perceived barriers.
Intended Audience:
- Pharmacists
- Pharmacy Technicians
Learning Objectives:
Following completion of this activity, participants will be able to:
- Discuss ISMP Guidelines for Sterile Compounding and the Safe Use of Sterile Compounding Technology
- Describe sterile compounding operations and the roles of technology to improve safety
- List common objectives with the use of technology and how organizations can overcome perceived barriers
Introduction and Overview:
Matthew Grissinger, RPh, FISMP, FASCP, Director of Education, ISMP
Speaker(s):
Review of Sterile Compounding Safety and the new ISMP Guidelines for Sterile Compounding and the Safe Use of Sterile Compounding Technology
Christina Michalek, BSc Pharm, RPh, FASHP, Director of Membership & PSO, ISMP
Overview of Sterile Compounding Operations and Use of Technology
Kevin Hansen, PharmD, MS, BCPS, BCSCP, Director of Pharmacy, Cone Health
Common Objections with the Implementations of Technology and How to Overcome Perceived Barriers
Laura K. Mark, PharmD, MS, MHM, FASHP, FABC, Vice President, Pharmacy, Allegheny Health Network
This activity is supported by Omnicell.
CE Accreditation
Pharmacists and Pharmacy Technicians
This CE activity is jointly provided by ProCE, LLC and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-22-213-L05-P/T has been assigned to this live knowledge-based CE activity (initial release date December 5, 2022). This activity is approved for 1.5 contact hour (0.15 CEU) in states that recognize ACPE providers. This activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.
